pa旗舰厅

2019

• Oct 10, 2019

  Jacobio Receives IND Approval for SHP2 Inhibitor JAB-3312 from China CDE

  pa旗舰厅: [More]
• Sep 16, 2019

  Jacobio Enrolled First Patient in a Clinical Study of JAB-3312 in U.S.

  pa旗舰厅: [More]
• Jul 9, 2019

  Jacobio Receives IND Approval for SHP2 Inhibitor JAB-3312 from U.S. FDA

  pa旗舰厅: [More]
• Jun 19, 2019

  Jacobio's Innovative Drug Awarded Orphan Drug Designation for the Treatment of Esophageal Cancer by US FDA

  pa旗舰厅: [More]